Association of serum irisin with gestational diabetes mellitus
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20250169Keywords:
Insulin-like growth factor, Irisin, Pregnancy, Gestational diabetes mellitusAbstract
Background: Gestational diabetes mellitus (GDM) is a condition characterized by glucose intolerance with onset during pregnancy, increasing risks to both mother and child. Recent studies have focused on irisin, a hormone linked to energy metabolism and insulin sensitivity, to understand its role in GDM. This study aimed to explore the relationship between serum irisin levels and the incidence of GDM.
Methods: This prospective diagnostic accuracy study was conducted at the outpatient Department of Fetomaternal Medicine and the Department of Obstetrics and Gynecology at BSMMU in Dhaka from July 2021 to June 2022. According to the inclusion criteria, 65 pregnant women who were non-GDM at 11-14 weeks were selected purposively. Serum irisin levels were measured in these non-diabetic participants using an enzyme-linked immunosorbent assay (ELISA) kit. The participants were divided into two groups: those with reduced irisin levels and those with normal irisin levels. Data were then analyzed using statistical package for the social sciences (SPSS) version 23.0 software.
Results: Among the low irisin group, 36.4% were diagnosed with GDM, while 63.6% remained euglycemic. In the high irisin group, 97.7% remained euglycemic, and 2.3% developed GDM. Overall, 14% of respondents were with GDM across both groups. The ROC analysis for detecting GDM based on irisin levels showed statistically significant results with an AUC of 0.834. A cut-off value of ≤0.287 had 88.9% sensitivity and 75% specificity, leading to 76.9% accuracy. The PPV was 36.4%, and the NPV was 97.7%. The mean serum irisin level was significantly lower in mothers with GDM compared to non-GDM mothers (p=0.001).
Conclusions: The maternal serum irisin level is found to be lower in pregnant women with GDM compared to those without GDM. Therefore, in pregnancy, maternal serum irisin levels may be useful as a biomarker for detection of GDM.
Metrics
References
Resnik R, Lockwood CJ, Moore TR, Greene MF, Copel JA. Creasy and Resnik’s maternal-fetal medicine: Principles and Practice. Elsevier Science Health Science; 8th edition. 2013;281-324.
Minschart C, Beunen K, Benhalima K. An Update on Screening Strategies for Gestational Diabetes Mellitus: A Narrative Review. Diabetes Metab Syndr Obes. 2021;14:3047-76. DOI: https://doi.org/10.2147/DMSO.S287121
Parrettini S, Caroli A, Torlone E. Nutrition and Metabolic Adaptations in Physiological and Complicated Pregnancy: Focus on Obesity and Gestational Diabetes. Front Endocrinol (Lausanne). 2020;11:611929. DOI: https://doi.org/10.3389/fendo.2020.611929
Mezza T, Cinti F, Cefalo CMA, Pontecorvi A, Kulkarni RN, Giaccari A. β-Cell Fate in Human Insulin Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity. Diabetes. 2019;68(6):1121-9. DOI: https://doi.org/10.2337/db18-0856
Alejandro EU, Mamerto TP, Chung G, Villavieja A, Gaus NL, Morgan E, et al. Gestational Diabetes Mellitus: A Harbinger of the Vicious Cycle of Diabetes. Int J Mol Sci. 2020;21(14):5003. DOI: https://doi.org/10.3390/ijms21145003
Aydin S, Kuloglu T, Aydin S. Copeptin, adropin and irisin concentrations in breast milk and plasma of healthy women and those with gestational diabetes mellitus. Peptides. 2013;47:66-70. DOI: https://doi.org/10.1016/j.peptides.2013.07.001
Al-Ghazali MJ, Ali HA, Al-Rufaie MM. Serum irisin levels as a potential marker for diagnosis of gestational diabetes mellitus. Acta Biomed. 2020;91(1):56-63.
Marrano N, Biondi G, Borrelli A, Cignarelli A, Perrini S, Laviola L, Giorgino F, Natalicchio A. Irisin and Incretin Hormones: Similarities, Differences, and Implications in Type 2 Diabetes and Obesity. Biomolecules. 2021;11(2):286. DOI: https://doi.org/10.3390/biom11020286
Abdelazem AS, Assaf SAFM, Gouda A. An Overview of Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1 Alpha. J Cardiovasc Dis Res. 2021;12(7):434-7.
Wenz T. Regulation of mitochondrial biogenesis and PGC-1α under cellular stress. Mitochondrion. 2013;13(2):134-42. DOI: https://doi.org/10.1016/j.mito.2013.01.006
Yang XY, Tse MCL, Hu X, Jia WH, Du GH, Chan CB. Interaction of CREB and PGC-1α Induces Fibronectin Type III Domain-Containing Protein 5 Expression in C2C12 Myotubes. Cell Physiol Biochem. 2018;50(4):1574-84. DOI: https://doi.org/10.1159/000494655
Maak S, Norheim F, Drevon CA, Erickson HP. Progress and Challenges in the Biology of FNDC5 and Irisin. Endocr Rev. 2021;42(4):436-56. DOI: https://doi.org/10.1210/endrev/bnab003
Arhire LI, Mihalache L, Covasa M. Irisin: A Hope in Understanding and Managing Obesity and Metabolic Syndrome. Front Endocrinol (Lausanne). 2019;10:524. DOI: https://doi.org/10.3389/fendo.2019.00524
Dinas PC, Lahart IM, Timmons JA, Svensson PA, Koutedakis Y, Flouris AD, et al. Effects of physical activity on the link between PGC-1a and FNDC5 in muscle, circulating Ιrisin and UCP1 of white adipocytes in humans: A systematic review. F1000Res. 2017;6:286. DOI: https://doi.org/10.12688/f1000research.11107.1
Jesmin S, Akter S, Akashi H, Al-Mamun A, Rahman MA, Islam MM, et al. Screening for gestational diabetes mellitus and its prevalence in Bangladesh. Diabetes Res Clin Pract. 2014;103(1):57-62. DOI: https://doi.org/10.1016/j.diabres.2013.11.024
Yue S, Thi VTK, Dung LP, Nhu BTH, Kestelyn E, Thuan DT, et al. Clinical consequences of gestational diabetes mellitus and maternal obesity as defined by asian BMI thresholds in Viet Nam: a prospective, hospital-based, cohort study. BMC Pregnancy Childbirth. 2022;22(1):195. DOI: https://doi.org/10.1186/s12884-022-04533-1
Zhu Y, Zhang C. Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective. Curr Diab Rep. 2016;16(1):7. DOI: https://doi.org/10.1007/s11892-015-0699-x
Abu-Heija AT, Al-Bash MR, Al-Kalbani MA. Effects of maternal age, parity and pre-pregnancy body mass index on the glucose challenge test and gestational diabetes mellitus. J Taibah Univ Med Sci. 2017;12(4):338-42. DOI: https://doi.org/10.1016/j.jtumed.2017.01.005
Khorasani ZM, Besharat M, Mehrad-Majd H, Mohammadi SA, Mahmoudinia M. Comparison irisin peptide serum level in pregnant women with and without gestational diabetes mellitus: A case-control study. Endocrinol Diabetes Metab. 2022;5(6):e370. DOI: https://doi.org/10.1002/edm2.370
Ural UM, Sahin SB, Tekin YB, Cüre MC, Sezgin H. Alteration of maternal serum irisin levels in gestational diabetes mellitus. Ginekol Pol. 2016;87(5):395-8. DOI: https://doi.org/10.5603/GP.2016.0013
Piya MK, Harte AL, Sivakumar K, Tripathi G, Voyias PD, James S, et al. The identification of irisin in human cerebrospinal fluid: influence of adiposity, metabolic markers, and gestational diabetes. Am J Physiol Endocrinol Metab. 2014;306(5):E512-8. DOI: https://doi.org/10.1152/ajpendo.00308.2013
Downloads
Published
How to Cite
Issue
Section
